Patents by Inventor Klaus Jost

Klaus Jost has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080228006
    Abstract: The invention relates to a method for largely eliminating chlorine compounds from organic isocyanates or isocyanate mixtures by contacting said isocyanates or isocyanate mixtures with a water-containing inert gas flow or an organic material having a cation-exchanging effect. The inventive method allows the isocyanates to be gently freed from chorine-containing compounds and is particularly suitable for temperature-sensitive isocyanates.
    Type: Application
    Filed: December 10, 2005
    Publication date: September 18, 2008
    Applicant: LANXESS DEUTSCHLAND GMBH
    Inventors: Andreas Job, Klaus Jost, Hans-Ulrich Dummersdorf
  • Publication number: 20060193786
    Abstract: The invention relates to pharmaceutical compositions for nasal application, comprising selected CGRP antagonists which are described in WO 98/11128, as well as a process for the preparation thereof.
    Type: Application
    Filed: May 19, 2006
    Publication date: August 31, 2006
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Bernd Kruss, Ulrich Busch, Klaus Jost, Marc Gaiser
  • Patent number: 6784219
    Abstract: The present invention relates to polyurethane cast elastomers which are prepared from higher molecular weight polyhydroxy compounds, durene diisocyanate and low molecular weight chain-lengthening and/or crosslinking agents. These elastomers are particularly useful for the production of moldings exposed to high mechanical stresses.
    Type: Grant
    Filed: January 15, 2000
    Date of Patent: August 31, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Peter Heitkämper, Klaus Jost, Eduard Mayer, Thomas Münzmay, Joachim Wagner, Christian Wolfrum
  • Publication number: 20040076587
    Abstract: The invention relates to pharmaceutical compositions for nasal application, comprising selected CGRP antagonists which are described in WO 98/11128, as well as a process for the preparation thereof.
    Type: Application
    Filed: June 17, 2003
    Publication date: April 22, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Bernd Kruss, Ulrich Busch, Klaus Jost, Marc Anton Gaiser
  • Publication number: 20030135008
    Abstract: The present invention relates to polyurethane cast elastomers which are prepared from higher molecular weight polyhydroxy compounds, durene diisocyanate and low molecular weight chain-lengthening and/or crosslinking agents. These elastomers are particularly useful for the production of moldings exposed to high mechanical stresses.
    Type: Application
    Filed: January 15, 2000
    Publication date: July 17, 2003
    Inventors: Peter Heitkamper, Klaus Jost, Eduard Mayer, Thomas Munzmay, Joachim Wagner, Christian Wolfrum
  • Patent number: 6486346
    Abstract: Durene diisocyanate is prepared by reacting durene with nitric acid in sulfuric acid, catalytic hydrogenation of the dinitrodurene that is formed, and phosgenation of the resultant durene diamine in a conventional manner. The intermediate products dinitrodurene and durene diamine do not have to be worked up in a complicated manner as solid products, but can be worked up in dissolved form. The intermediate products dinitrodurene and durene diamine do not have to be isolated and purified in a complicated manner. but can be processed directly after preparation. Another advantage of this process is that only a single organic solvent need be used for the overall preparation process. Separation and re-use of spent acid in the conversion of durene with nitric acid also renders the process of the present invention significantly less environmentally harmful than the known processes of the prior art.
    Type: Grant
    Filed: December 14, 1999
    Date of Patent: November 26, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Peter Heitkämper, Klaus Jost, Stefan Penninger
  • Patent number: 5925783
    Abstract: Isocyanates are prepared by a continuous process by reacting appropriate primary amines with phosgene in the presence of an isocyanate as solvent, the primary amine optionally dissolved in an inert organic solvent being reacted with phosgene, which is dissolved in the isocyanate, at temperatures of 60 to 150.degree. C. and at pressures of 1 to 30 bar (10.sup.5 to 3.10.sup.6 Pa) to obtain the corresponding isocyanate, wherein the molar ratio of phosgene to amine used is 4:1 to 1:1, and the isocyanate used as solvent is solids-free and has a value for hydrolysable chlorine of less than 2%.
    Type: Grant
    Filed: May 12, 1997
    Date of Patent: July 20, 1999
    Assignee: Bayer Aktiengesellschaft
    Inventors: Klaus Jost, Gunter Hammen, Rudolf Sundermann
  • Patent number: 5786438
    Abstract: The present invention relates to mixtures of cycloaliphatic diisocyanates corresponding to formula 1) ##STR1## wherein R represents a saturated, linear, aliphatic hydrocarbon residue having 8 to 15 carbon atoms.The present invention also relates to a process for the preparation of these diisocyanate mixtures and to their use for the production of polyisocyanate addition products.
    Type: Grant
    Filed: March 31, 1997
    Date of Patent: July 28, 1998
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hans-Joachim Scholl, Bernhard Jansen, Klaus Jost, Rolf-Volker Meyer
  • Patent number: 5552507
    Abstract: Diisocyanates containing carboxylic acid ester groups corresponding to the formula: ##STR1## in which R and R.sup.1 represent specified groups are produced by phosgenation of the corresponding diamines, optionally present in the form of an ammonium salt. These diisocyanates are useful as starting materials in the production of plastics containing urethane and/or urea groups and as starting materials for the production of intermediate products used for the production of such plastics.
    Type: Grant
    Filed: May 3, 1995
    Date of Patent: September 3, 1996
    Assignee: Bayer Aktiengesellschaft
    Inventors: Christian Wamprecht, Klaus Jost, Stefan Penninger